ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Cross Above Fifty Day Moving Average – Here’s Why

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $17.21 and traded as high as $22.59. ChronoScale Corporation Common Stock shares last traded at $17.64, with a volume of 805,758 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a report on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $6.00.

ChronoScale Corporation Common Stock Trading Down 20.6%

The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The firm has a market cap of $62.80 million, a PE ratio of -3.28 and a beta of 0.99. The company’s fifty day moving average price is $17.21 and its two-hundred day moving average price is $12.03.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings data on Tuesday, April 28th. The company reported ($2.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($2.01). The business had revenue of $2.14 million during the quarter, compared to analysts’ expectations of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. As a group, sell-side analysts forecast that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Institutional investors have recently bought and sold shares of the company. Consolidated Portfolio Review Corp acquired a new stake in ChronoScale Corporation Common Stock during the 3rd quarter valued at $333,000. Citadel Advisors LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $198,000. Shay Capital LLC acquired a new position in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at $67,000. Virtu Financial LLC acquired a new position in ChronoScale Corporation Common Stock in the third quarter valued at $57,000. Finally, Geode Capital Management LLC increased its position in ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares in the last quarter. 6.42% of the stock is currently owned by hedge funds and other institutional investors.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.